A University of Florida researcher has developed a groundbreaking open-source computer program that uses artificial intelligence to analyze videos of patients with Parkinson’s disease and other movement disorders. The tool, called VisionMD, helps doctors more accurately monitor subtle motor changes, improving patient care and advancing clinical research. Diego Guarin, Ph.D.,Continue Reading
Hailshadow/iStock via Getty Images Shares of Annovis Bio (NYSE:ANVS) more than doubled in value on Tuesday after the company said its lead asset, buntanetap, was found to be safe and effective in improving the physical and cognitive functions of patients with early Parkinson’s disease. Updating data from its Phase 3Continue Reading
AbbVie’s (NYSE:ABBV) new drug application for its Parkinson’s disease combination therapy has been denied approval by the FDA. In a complete response letter sent to the drugmaker, the U.S. drug regulator cited observations that were identified during inspection of a third-party manufacturer listed in the application. The inspection at theContinue Reading
